Filter posts

Repositioning Drugs for Parkinson's Disease

Last month, The Michael J. Fox Foundation (MJFF) announced the launch of its Repositioning Drugs …

Resistance is Futile – SuperDrugs for SuperBugs

“MRSA’s kill 100,000 people a year, more than AIDS,” said Mark Leuchetenberger, President and CEO, …

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

Insights in to the molecular and genetic basis of disease are driving new product and …

Ten Years After 9/11 and the Anthrax Attacks

Yesterday, the U.S. Senate Committee on Homeland Security and Governmental Affairs held a hearing entitled, …

Confessions of a Cancer-Free Cancer Patient

By Sandra Dennis, Deputy General Counsel for Healthcare, the Biotechnology Industry Organization October is breast …

Bioterrorism: Ten Years Later

By Bob Graham, Jim Talent, Randy Larsen & Lynne Kidder of The WMD Center Ten …

BIO's New Personalized Medicine and Diagnostics Working Group

The Biotechnology Industry Organization (BIO) represents a diverse portfolio of companies throughout the continuum of …

Biotechnology Delivers Medical Discoveries to Benefit Women Facing Breast Cancer

By Marc S. Hurlbert, Ph.D., Executive Director, Avon Foundation Breast Cancer Crusade The field of breast …

Moving Beyond the Stem Cell Stalemate

By Michael J. Werner, Alliance for Regenerative Medicine For the past several years, attendees at the …

Anthrax Attacks 10 Year Anniversary: BioCentury Looks at Preparedness

A decade ago in the weeks following the terrorist attacks of September 11th, the nation …